Downgrading GoodRx to a sell rating on recent decline fundamentals. GoodRx's revenue growth is decelerating, with significant reliance on retail partnerships and cyclical transactional revenue, making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results